Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
Blue Owl Capital Holdings LP | 1,323,877 4.320% |
-350,000![]() (-20.91%) |
Filing History |
2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 6,357,928 8.480% |
946,638![]() (+17.49%) |
Filing History |
2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | AEON Biopharma, Inc. AEON |
Blue Owl Capital Holdings LP | 42,352 3.810% |
-4,053![]() (-8.73%) |
Filing History |
2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Blue Owl Capital Holdings LP | 1,079,321 4.200% |
-451,080![]() (-29.47%) |
Filing History |
2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | Marker Therapeutics, Inc. MRKR |
Blue Owl Capital Holdings LP | 554,250 5.180% |
554,250![]() (New Position) |
Filing History |
2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | Generation Asia I Acquisition Limited GAQ |
Blue Owl Capital Holdings LP | 0 0.000% |
-573,000![]() (Position Closed) |
Filing History |
2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | FS Credit Opportunities Corp. FSCO |
Blue Owl Capital Holdings LP | 50,000 16.670% |
50,000![]() (New Position) |
Filing History |
2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | LUMENT FIN TR INC RED LFTPRA |
Blue Owl Capital Holdings LP | 200,000 8.330% |
200,000![]() (New Position) |
Filing History |
2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | ARBOR RLTY TR INC ABRPRE |
Blue Owl Capital Holdings LP | 360,000 6.260% |
360,000![]() (New Position) |
Filing History |
2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Blue Owl Capital Holdings LP | 515,855 1.920% |
-977,397![]() (-65.45%) |
Filing History |
2024-11-14 5:05 pm Unchanged |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
Blue Owl Capital Holdings LP | 3,004,199 4.940% |
0 (Unchanged) |
Filing History |
2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
Blue Owl Capital Holdings LP | 2,010,972 3.450% |
-1,408,870![]() (-41.20%) |
Filing History |
2024-11-14 5:05 pm Sale |
2024-09-30 | 13G | Orchard Therapeutics plc ORTX |
Blue Owl Capital Holdings LP | 0 0.000% |
-15,596,600![]() (Position Closed) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN |
Blue Owl Capital Holdings LP | 3,095,069 7.000% |
1,860,309![]() (+150.66%) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
Blue Owl Capital Holdings LP | 1,530,401 6.000% |
198,099![]() (+14.87%) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR |
Blue Owl Capital Holdings LP | 4,166,829 6.530% |
752,361![]() (+22.03%) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Repare Therapeutics Inc. RPTX |
Blue Owl Capital Holdings LP | 3,372,499 7.930% |
250,000![]() (+8.01%) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Blue Owl Capital Holdings LP | 1,673,877 5.460% |
1,673,877![]() (New Position) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Context Therapeutics Inc. CNTX |
Blue Owl Capital Holdings LP | 4,091,118 8.480% |
4,091,118![]() (New Position) |
Filing History |
2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Nuveen Churchill Direct Lending Corp. NCDL |
Blue Owl Capital Holdings LP | 4,039,552 7.410% |
4,039,552![]() (New Position) |
Filing History |